StockMirror — Stock Screener

SRF Q3 FY26 Results & Earnings Analysis

Sentiment: Good (Confidence: high)

Earnings Summary

SRF delivered a quarter of healthy top-line growth (6%) and strong bottom-line expansion (PAT +60% YoY), driven by a record performance in Fluorochemicals. The Chemicals Business grew 22% YoY. Headwinds persisted in Specialty Chemicals (Chinese pricing pressure, agro demand deferment) and Technical Textiles (competitive imports). Management is proactively investing in growth (new generation gases, pharma) while managing costs. The outlook is cautiously positive for Q4 recovery in Specialty Chemicals, but near-term challenges from tariffs and competition remain. The balance sheet is strong, supporting a significant capex plan focused on the Kigali Amendment transition.

Management Tone

Revenue Growth Drivers

Growth vs Margin Focus

Strategy emphasizes operational excellence and cost management to protect margins while investing for growth (new gases, pharma, value-added products). In the short term, chose to protect market share over margins in Specialty Chemicals.

About SRF LIMITED

SRF LIMITED (SRF) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.

Explore More